Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System
Caution: The iLet Bionic Pancreas is an investigational device limited by Federal law to investigational use. Not available for sale.
Steven Russel…
Nicolette, Inc. Awarded Patent for NicoBoard Technology
LONG BEACH, Calif. – January 4, 2023 – (Newswire.com)
Nicolette, I…
Hecaray Presents an Intelligent Sleep-Aid Solution at CES, Las Vegas, 2023
Enhance Sleep Quality With Hecaray Nelf’s Contactless, Accurate Sleep Tracker
SHANGHAI, China – January 4, 2023 – (Newswire.com)
Hecaray Nelf is proud to present one of the most cutting-edge sleep-aid solutions in the world at CES, revolutionizing how sleep trackers measure sleep by being specific and touchless, providing the optimal customized sleep solutions to thousands of people they need. As a leading sleep solution provider that can precisely track the sleep cycle and offers meaningful sleep solutions to enhance people’s quality of life – will be exhibited at North Hall (No. 8066), CES in Las Vegas, which starts from Jan. 5 through until Jan. 8.
Sleep is a tricky friend these days – with 30 percent of adults in America not getting enough sleep, stress may overtake the body when people don’t get enough sleep. With the Hecaray Nelf Sleep Tracking Monitor and App – recording the whole night’s sleep, detecting the sleep stages, and analyzing obstructive sleep apnea (OSA), and heart rate variability (HRV) – Nelf will use the monitored data to understand people’s sleep patterns and provide an intelligent solution to improve their sleep quality by emitting special sounds and light in optimal time.
Hecaray Nelf monitors the heart rate variability (HRV), breaths per minute, as well as motion while people sleep – anything that could affect the statistics. After monitoring all of this information, Nelf identifies whether or not users are about to go into light or deep sleep and then recommends a remedy according to what it knows about sleep situations.
It’s been proven time and time again that these other products – common competitors such as wearables and contact-based sleep tech – are just plain bad for accuracy. They’re based on the false premise of wearing something when users sleep, which doesn’t sound comfortable either. In opposition, Hecaray Nelf can provide a hospital-level sleep report, which people can get to know about the signs of Sleep Apnea at home without having to go through painful PSG tests in hospitals or clinics.
Hecaray Nelf features various sounding programs, such as a library of white noise, which has been verified by scientific research to enhance sleep. It also features an intelligent 2-stage wakeup alarm to help people wake up without morning grogginess, or lights that control how much melatonin people produce at night and dawn – all three working together in order to provide users with better quality sleep.
Hecaray is an intelligent sleep all-in-one sleep solution for a better quality of life through its product. With Hecaray’s sleep-tracking technology, users will be able to track their own personal data and increase their overall well-being by receiving the optimal sleep solutions tailored by Hecaray. For more information about Hecaray Nelf, click here.
Contact Information:
Hecaray PR team
Hecaray
Press Release Service
by
Newswire.com
Original Source:
Hecaray Presents an Intelligent Sleep-Aid Solution at CES, Las Vegas, 2023
Who Are the Scientists Probing the Biology Behind Autism?
A new book from Spectrum profiles the condition’s research community, revealing surprises about its founders, current leaders and rising stars.
Chronicle of a Field Retold: Autism Science in Profile
The cover of Spectrum’s new book \”Chronicle of a Field Retold: Autism Science in Profile\” – featuring abstract shapes on a beige grid background.
NEW YORK – January 3, 2023 – (Newswire.com)
Who are the scientists who devote their careers to studying autism — arguably one of the most challenging neurodevelopmental conditions to explain? And what does that say about them? About the field? That’s exactly what Spectrum magazine (www.spectrumnews.org) — the leading source for expert news and opinion on autism science — sought to answer with its fifth annual book, “Chronicle of a Field Retold: Autism Science in Profile,” freely available for download on the site today.
The book opens with a surprising retelling of the field’s first movers: In “The new history of autism,” journalist David Dobbs reveals the scientists whose forgotten contributions predated or enabled those of Leo Kanner and Hans Asperger, long credited as the sole founders of autism research. The story features original collage illustrations by award-winning graphic designer Alex Merto and rare photos discovered only two years ago in the archives of a Moscow clinic named after the pioneering child psychiatrist Grunya Sukhareva.
“Autism Science in Profile” continues with a tour of today’s key players, organized alphabetically. These scientist profiles show that autism researchers are, perhaps unsurprisingly, a heterogeneous bunch. Not only do their academic areas of interest vary widely, but outside of the lab they are marathon runners, mountaineers, bicyclists and basketball coaches; foodies, yogis, musicians and spelling-bee champions; former teachers, farmers, Peace Corps volunteers and emergency medical technicians.
For all of their differences, more than a few share deep connections to autism and disability, and core descriptions about them recur — creative, persistent, adaptable and collaborative. Published over the past 12 years, the profiles have been updated in this volume to include the scientists’ highly cited papers, compiled using Clarivate’s Web of Science, and 2022 news from the researchers themselves about career shifts and significant recent accomplishments.
“We hope these pages show autism research in an exciting time of flux, propelled by what these scientists care about, what questions drive their work and where they think the field is headed next,” says Spectrum‘s deputy editor, Kristin Ozelli.
End pages for various sections include QR codes to additional profiles and “beyond the bench” portraits of scientists’ lives outside the lab. Additional spreads feature an illustration that begins to trace eight decades of apprenticeship among autism researchers and a gatefold list of 40 up-and-coming scientists under 40 years old — both informed by asking our sources and profile subjects about significant mentor relationships during their careers.
Like Spectrum‘s previous two titles, “Chronicle of a Field Retold: Autism Science in Profile” was designed by award-winning graphic designer Catherine Casalino. The book also features original profile illustrations by Rebecca Clarke.
Contact Information:
Anastasia Greenebaum
Communications Director
646-654-0066
Press Release Service
by
Newswire.com
Original Source:
Who Are the Scientists Probing the Biology Behind Autism?
CodaPet Expands Its Network of Licenced Veterinarians in Fresno for In-Home Pet Euthanasia Services
The startup provides peaceful at-home euthanasia to ease the passing of dogs and cats at home, surrounded by loved ones.
FRESNO,…
AQuity Solutions Extends Market Leadership in Security and Quality Practices With Dual ISO Achievements
Document Capture and Coding Solutions Leader Achieves ISO 27001 Security and ISO 9001 Quality Certification, Following November 2022 SOC 2® Type 2 Certification.
…
FallCall Solutions Partners With HSC Technology Group to Launch iPhone and Android-Based Medical Alert System in Australia
FallCall\/HSCTG Partnership New medical alert system to launch in Australia.
TRUMBULL, Conn. – January 3, 2023 – (…
Ampronix, LLC the Leader in Medical Imaging Technology Announces New CEO A. Burton Tripathi PhD
For over 40 years, Ampronix has led the way in medical imaging innovation and design. The name “Ampronix” has become synonymous with excellence, and Ampronix has evolved into a renowned master distributor of the medical industry’s top brands.
Ampronix LLC CEO A. Burton Tripathi PhD
Ampronix LLC CEO A. Burton Tripathi PhD
IRVINE, Calif. – December 30, 2022 – (Newswire.com)
Founded in 1982 and located in Irvine, California, Ampronix, LLC is a renowned authorized master distributor of the medical industry’s top brands currently selling to 154+ countries as well as a world-class manufacturer of innovative technology. We are happy to announce A. Burton Tripathi, Ph.D., as CEO. Dr. Tripathi succeeds Aladdin Doroudi, who is retiring and has guided the company to its strong position in the market through his dedicated leadership over the last 22 years.
About A. Burton Tripathi PhD
Before Ampronix, LLC, Dr. Tripathi was Head of Visualization R&D at Alcon Inc. He guided the strategic planning, ideation, development, and launch of the next generation of visualization equipment -transforming the practice of surgery with a fully digital operating microscope.
Before Alcon, Dr. Tripathi was the CEO of TrueVision Systems, Inc.
Dr. Tripathi negotiated and led a $145M sale and integration of TrueVision Systems to Alcon. In 2018 Dr. Tripathi guided the complex legal and financial transaction of spinning out the non-ophthalmology business of TrueVision into TrueDigital Surgery. This complex structure provided a win-win solution, preserving jobs and allowing both Alcon and TrueDigital to maximize shareholder value while continuing to deliver cutting-edge solutions.
Before helming TrueVision Systems, Dr. Tripathi served as Chief Technology Officer and VP, Product Development, leading passionate teams of 50+ engineers and support staff in the mission to revolutionize microsurgery by bringing 3D digital imaging with Augmented Reality (AR) to the optical microscope. Dr. Tripathi’s team worked to change the face of neurosurgery, ophthalmology, and other surgical disciplines by improving surgical precision, enabling new digital applications, and inventing new technologies.
Dr. Tripathi holds a Ph.D. from the California Institute of Technology in Mechanical Engineering and a B.S. in Mechanical and Aerospace Engineering from Cornell University.
About Ampronix, LLC
Ampronix was recently awarded the “President’s E-Award,” the highest honor given to U.S. exporters and Exporter of the Year for Orange County, California. Ampronix is proud to represent customers worldwide through its dedication to meeting the growing needs of the medical community with its extensive product knowledge, outstanding customer service, and groovy team of sales professionals. Ampronix has focused on putting clients’ satisfaction first, as professionalism is their cornerstone. Ampronix has been an established member of the Irvine community since its inception in 1982. Ampronix is a beacon in the community and continually strives to increase its global presence through industry-leading exporting efforts. With reliability, safety, and quality at the core of its philosophy, Ampronix is dedicated to helping others save lives and create a healthier tomorrow for future generations.
Contact Information:
Michael Thomas
Director of Marketing
949-273-8000
Press Release Service
by
Newswire.com
Original Source:
Ampronix, LLC the Leader in Medical Imaging Technology Announces New CEO A. Burton Tripathi PhD
Cyber Security Services Announces Plan to Be the First U.S. Cybersecurity Company to Provide Exclusive Services for Technology Distributors and Their Partners
As the first U.S. cybersecurity company to provide exclusive cybersecurity, compliance, and risk management services for technology distributors and their partners, CSS is on a mission to help partners bring high-quali…
Physicians for Informed Consent (PIC) Updates Its ‘Aluminum – Vaccine Risk Statement’: Document Includes Data on Association Between Aluminum in Vaccines and Childhood Asthma
According to PIC, adverse effects of aluminum may not be restricted to neurological conditions*
NEWPORT BEACH, Calif. – December 28, 2022 – (Newswire.com)
Physicians for Informed Consent (PIC) has released an update to its Aluminum – Vaccine Risk Statement (VRS) titled “Aluminum in Vaccines: What Parents Need to Know.” The concise, two-page educational document — which serves to answer important questions about the risks of aluminum-containing vaccines — now includes important data about a study’s link between aluminum in vaccines and asthma. Asthma is a disease that affects the lungs. It causes repeated episodes of wheezing, breathlessness, chest tightness, and nighttime or early morning coughing.
Developed from data compiled by the Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), and the Agency for Toxic Substances and Disease Registry (ATSDR), the PIC document provides reader-friendly Q&As on topics such as:
- Why is aluminum in vaccines?
- Which vaccines contain aluminum?
- How much aluminum is in vaccines?
- Is exposure to aluminum from vaccines safe?
The document explains that both the FDA and ATSDR have raised concerns about the negative effects of aluminum exposure in humans. Scientific studies have shown that small amounts of aluminum can interfere with cellular and metabolic processes in the nervous system. Some of the most damaging effects of aluminum range from motor skill impairment to encephalopathy (altered mental state, personality changes, difficulty thinking, loss of memory, seizures, coma, and more).
Studies have also shown that adverse effects of aluminum may not be restricted to neurological conditions.* A study referenced in the PIC document and published in Academic Pediatrics found that asthma occurred in 1 in 183 vaccinated children for every 1 mg (1,000 mcg) increase in aluminum exposure. In the United States, up to 22 doses of aluminum-containing vaccines are administered to children, with 11 doses administered from birth to 6 months of age.
“Overexposure to aluminum may lead to significant harm,” said Dr. Shira Miller, founder and president of Physicians for Informed Consent. “In California, where PIC is headquartered, since Senate Bill 277 (SB 277) was enacted in 2015, numerous doses of aluminum-containing vaccines are mandated for public and private K-12 school attendance — with no exceptions for religious or personal belief exemptions. PIC asserts that vaccine mandates are unscientific and unethical and a threat to public health. SB 277, and any other law that coerces vaccination, needs to be repealed.”
To read or download the educational document “Aluminum in Vaccines: What Parents Need to Know,” please visit physiciansforinformedconsent.org/aluminum.
* In 2008, the Agency for Toxic Substances and Disease Registry (ATSDR), a division of HHS, used studies of the neurotoxic effects of aluminum to determine that no more than 1 milligram (mg) (1,000 micrograms [mcg]) of aluminum per kilogram (kg) of body weight should be taken orally per day to avoid aluminum’s negative effects.
Physicians for Informed Consent is a 501(c)(3) nonprofit educational organization focused on science and statistics. PIC delivers data on infectious diseases and vaccines, and unites doctors, scientists, healthcare professionals, attorneys, and families who support voluntary vaccination. In addition, the PIC Coalition for Informed Consent consists of over 300 U.S. and international organizations. Click here to make a donation.
Contact Information:
Greg Glaser
General Counsel
925-642-6651
Press Release Service
by
Newswire.com
